Gerold Schuler Selected Research

Gerold Schuler Research Topics

Disease

73	Neoplasms (Cancer) 05/2024 - 05/2002
65	Melanoma (Melanoma, Malignant) 11/2021 - 05/2002
10	Neoplasm Metastasis (Metastasis) 04/2022 - 08/2004
6	Pemphigus (Pemphigus Vulgaris) 05/2006 - 01/2003
5	Skin Neoplasms (Skin Cancer) 07/2019 - 01/2016
4	Uveal melanoma 05/2024 - 12/2005
4	Infections 10/2019 - 04/2007
4	Lymphoma (Lymphomas) 08/2019 - 05/2006
4	Leukemia 08/2019 - 12/2005
4	Bullous Pemphigoid (Pemphigoid) 02/2006 - 11/2002
3	Eosinophilia 03/2020 - 01/2017
3	Vitiligo 09/2014 - 05/2012
3	Human Influenza (Influenza) 06/2005 - 06/2003
2	Hypersensitivity (Allergy) 09/2021 - 01/2017
2	Merkel Cell Carcinoma 06/2020 - 07/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 06/2019 - 07/2006
2	Myocarditis (Carditis) 01/2019 - 01/2018
2	Brain Neoplasms (Brain Tumor) 06/2018 - 02/2008
2	Disease Progression 01/2017 - 08/2004
2	Inflammation (Inflammations) 01/2017 - 02/2006
2	Colitis 06/2016 - 06/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2007 - 01/2002
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Sclerosing Cholangitis 01/2023
1	HIV Infections (HIV Infection) 01/2020
1	Communicable Diseases (Infectious Diseases) 10/2019
1	Dermatitis 07/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2019
1	Myasthenia Gravis 01/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019

Drug/Important Bio-Agent (IBA)

29	AntigensIBA 05/2024 - 01/2002
21	Peptides (Polypeptides)IBA 05/2024 - 05/2002
14	CytokinesIBA 09/2021 - 04/2003
12	VaccinesIBA 01/2023 - 04/2005
10	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2006
10	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2002
10	IpilimumabIBA 01/2019 - 01/2013
9	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 04/2003
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
8	Chimeric Antigen ReceptorsIBA 01/2023 - 10/2014
8	Messenger RNA (mRNA)IBA 01/2022 - 01/2005
7	Immune Checkpoint InhibitorsIBA 03/2020 - 01/2018
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 09/2006
7	NivolumabIBA 01/2019 - 01/2016
7	AutoantibodiesIBA 03/2006 - 11/2002
6	EpitopesIBA 10/2019 - 11/2002
6	pembrolizumabIBA 01/2019 - 01/2016
6	MART-1 AntigenIBA 01/2013 - 03/2005
5	LigandsIBA 01/2019 - 07/2002
5	AntibodiesIBA 01/2016 - 06/2004
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 01/2002
3	Monophenol Monooxygenase (Tyrosinase)IBA 08/2015 - 05/2005
3	HLA-DPw4 antigenIBA 05/2009 - 01/2004
3	HLA-A1 Antigen (HLA A1 Antigen)IBA 05/2008 - 07/2002
3	DesmogleinsIBA 03/2006 - 08/2005
3	Desmoglein 3IBA 01/2006 - 01/2003
3	Inosine Monophosphate (IMP)IBA 06/2005 - 06/2003
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2017
2	ChemokinesIBA 09/2021 - 04/2007
2	Cancer VaccinesIBA 03/2020 - 02/2011
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 10/2019 - 06/2007
2	Sunscreening Agents (Sunscreens)IBA 07/2019 - 03/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2018 - 12/2007
2	Infliximab (Remicade)FDA Link 06/2016 - 03/2005
2	HMW-MAAIBA 12/2015 - 05/2009
2	CD40 Ligand (CD40L)IBA 08/2015 - 04/2012
2	Interferon-alpha (Interferon Alfa)IBA 02/2010 - 04/2008
2	Proteoglycans (Proteoglycan)IBA 05/2009 - 06/2007
2	ChondroitinIBA 05/2009 - 06/2007
2	Chondroitin Sulfate ProteoglycansIBA 05/2009 - 06/2007
2	HLA-A*02:01 antigenIBA 07/2007 - 06/2005
2	Chemokine ReceptorsIBA 04/2007 - 02/2006
2	Desmoglein 1IBA 01/2006 - 08/2005
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2024
1	Sorafenib (BAY 43-9006)FDA Link 04/2022
1	thiamine triphosphorate (TTP)IBA 04/2022
1	CollagenIBA 10/2020
1	C-Reactive ProteinIBA 10/2019
1	ProcalcitoninIBA 10/2019
1	CD19-specific chimeric antigen receptorIBA 06/2019
1	Eosinophil Cationic ProteinIBA 03/2019
1	tremelimumabIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	CateninsIBA 01/2019
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	Surface Antigens (Surface Antigen)IBA 08/2018
1	Small Interfering RNA (siRNA)IBA 01/2018

Therapy/Procedure

40	Immunotherapy 05/2024 - 10/2002
37	Therapeutics 01/2023 - 07/2002
4	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 10/2014
2	Radiotherapy 01/2018 - 02/2008
2	Lymph Node Excision (Lymph Node Dissection) 12/2017 - 02/2008
2	Aftercare (After-Treatment) 06/2016 - 06/2015
2	Phototherapy (Light Therapy) 09/2014 - 09/2014
2	Drug Therapy (Chemotherapy) 04/2008 - 12/2005